Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system
Type
Public
HQ
Seattle, US
Size (employees)
162 (est)
Website
omeros.com
Omeros is headquartered in Seattle, US

Key People at Omeros

Gregory A. Demopulos

Gregory A. Demopulos

Chairman and Chief Executive Officer
Wayne Wager

Wayne Wager

Director
Timothy M. Duffy

Timothy M. Duffy

Vice President, Business Development

Omeros Office Locations

Omeros has an office in Seattle
Seattle, US (HQ)
201 Elliott Ave

Omeros Data and Metrics

Omeros Financial Metrics

Omeros's revenue was reported to be $41.6 m in 2016
$, USD

Revenue (Y, 2016)

41.6 m

Revenue growth (Y, 2015 - Y, 2016), %

208%

Gross profit (Y, 2016)

40.2 m

Gross profit margin (Y, 2016), %

97%

Net income (Y, 2016)

(66.7 m)

EBIT (Y, 2016)

(54.3 m)

Market capitalization (23-Jun-2017)

1.1 b

Closing share price (23-Jun-2017)

26.6

Cash (31-Dec-2016)

2.2 m
Omeros's current market capitalization is $1.1 b.
$, USDFY, 2013FY, 2014FY, 2015Y, 2016

Revenue

1.6 m539 k13.5 m41.6 m

Revenue growth, %

(66%)2406%208%

Cost of goods sold

1 m1.4 m

Gross profit

12.5 m40.2 m

Gross profit Margin, %

92%97%

Operating expense total

52.1 m70.5 m84.7 m95.9 m

EBIT

(50.5 m)(70 m)(71.2 m)(54.3 m)

EBIT margin, %

(3157%)(12988%)(527%)(130%)

Interest expense

(2.4 m)(3.5 m)(3.6 m)(7.8 m)

Net Income

(39.8 m)(73.7 m)(75.1 m)(66.7 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.4 m354 k1.4 m2.2 m

Inventories

337 k472 k1.1 m

Current Assets

14.8 m9.2 m37.1 m60.3 m

PP&E

939 k782 k951 k1.2 m

Total Assets

16.5 m11.1 m49 m67.3 m

Accounts Payable

2.3 m4.9 m6.4 m2.5 m

Current Liabilities

11.9 m18.4 m16.3 m16.1 m

Additional Paid-in Capital

235.7 m285.1 m376.5 m432 m

Retained Earnings

(254.4 m)(328 m)(403.1 m)(469.9 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(39.8 m)(73.7 m)(75.1 m)(66.7 m)

Depreciation and Amortization

302 k326 k209 k300 k

Inventories

96 k(656 k)

Accounts Payable

4.2 m(319 k)

Cash From Operating Activities

(29.7 m)(58 m)(65.2 m)(51.5 m)

Purchases of PP&E

(204 k)

Cash From Investing Activities

7.9 m6.2 m(20.6 m)(16.3 m)

Long-term Borrowings

(1.5 m)

Cash From Financing Activities

21.7 m50.9 m86.8 m68.7 m

Interest Paid

1.7 m2.7 m4.2 m5.3 m
$, USDY, 2016

Revenue/Employee

256.9 k

Omeros Market Value History

Omeros Online and Social Media Presence

Omeros News and Updates

Omeros Company Life and Culture

You may also be interested in